9 research outputs found
The Role of Bmp- and Fgf Signaling Modulating Mouse Proepicardium Cell Fate
Bmp and Fgf signaling are widely involved in multiple aspects of embryonic development.
More recently non coding RNAs, such as microRNAs have also been reported to play
essential roles during embryonic development. We have previously demonstrated that
microRNAs, i.e., miR-130, play an essential role modulating Bmp and Fgf signaling during
early stages of cardiomyogenesis. More recently, we have also demonstrated that
microRNAs are capable of modulating cell fate decision during proepicardial/septum
transversum (PE/ST) development, since over-expression of miR-23 blocked while miR-
125, miR-146, miR-223 and miR-195 enhanced PE/ST-derived cardiomyogenesis,
respectively. Importantly, regulation of these microRNAs is distinct modulated by
Bmp2 and Fgf2 administration in chicken. In this study, we aim to dissect the
functional role of Bmp and Fgf signaling during mouse PE/ST development, their
implication regulating post-transcriptional modulators such as microRNAs and their
impact on lineage determination. Mouse PE/ST explants and epicardial/endocardial cell
cultures were distinctly administrated Bmp and Fgf family members. qPCR analyses of
distinct microRNAs, cardiomyogenic, fibrogenic differentiation markers as well as key
elements directly epithelial to mesenchymal transition were evaluated. Our data
demonstrate that neither Bmp2/Bmp4 nor Fgf2/Fgf8 signaling is capable of inducing
cardiomyogenesis, fibrogenesis or inducing EMT in mouse PE/ST explants, yet
deregulation of several microRNAs is observed, in contrast to previous findings in
chicken PE/ST. RNAseq analyses in mouse PE/ST and embryonic epicardium
identified novel Bmp and Fgf family members that might be involved in such cell fate
differences, however, their implication on EMT induction and cardiomyogenic and/or
fibrogenic differentiation is limited. Thus our data support the notion of species-specific
differences regulating PE/ST cardiomyogenic lineage commitment
Muscle Satellite Cell Heterogeneity: Does Embryonic Origin Matter?
Funding This work was partially supported by grants PID2019-10 7492GB-I00 (Ministerio de Ciencia e Innovacion, Spain) and 06030050P1 PROY I + D + I. FEDER ANDALUCIA (Junta de Andalucia, Spain). LR-O is recipient of a FPU grant (FPU17/03843).Muscle regeneration is an important homeostatic process of adult skeletal muscle
that recapitulates many aspects of embryonic myogenesis. Satellite cells (SCs) are
the main muscle stem cells responsible for skeletal muscle regeneration. SCs reside
between the myofiber basal lamina and the sarcolemma of the muscle fiber in a
quiescent state. However, in response to physiological stimuli or muscle trauma,
activated SCs transiently re-enter the cell cycle to proliferate and subsequently exit
the cell cycle to differentiate or self-renew. Recent evidence has stated that SCs
display functional heterogeneity linked to regenerative capability with an undifferentiated
subgroup that is more prone to self-renewal, as well as committed progenitor cells
ready for myogenic differentiation. Several lineage tracing studies suggest that such
SC heterogeneity could be associated with different embryonic origins. Although it has
been established that SCs are derived from the central dermomyotome, how a small
subpopulation of the SCs progeny maintain their stem cell identity while most progress
through the myogenic program to construct myofibers is not well understood. In this
review, we synthesize the works supporting the different developmental origins of SCs
as the genesis of their functional heterogeneity.Spanish Government PID2019-10 7492GB-I00FEDER ANDALUCIA (Junta de Andalucia, Spain) 06030050P1 PROY I + D + ISpanish Government FPU17/0384
Regulation of Epicardial Cell Fate during Cardiac Development and Disease: An Overview
This work was partially supported by grants BFU2015-67131 (Spanish Ministry of Economy and Competitiveness) and PID2019-107492GB-100 (Spanish Ministry of Science and Innovation).The epicardium is the outermost cell layer in the vertebrate heart that originates during
development from mesothelial precursors located in the proepicardium and septum transversum.
The epicardial layer plays a key role during cardiogenesis since a subset of epicardial-derived cells
(EPDCs) undergo an epithelial–mesenchymal transition (EMT); migrate into the myocardium; and
differentiate into distinct cell types, such as coronary vascular smooth muscle cells, cardiac fibroblasts,
endothelial cells, and presumably a subpopulation of cardiomyocytes, thus contributing to complete
heart formation. Furthermore, the epicardium is a source of paracrine factors that support cardiac
growth at the last stages of cardiogenesis. Although several lineage trace studies have provided
some evidence about epicardial cell fate determination, the molecular mechanisms underlying
epicardial cell heterogeneity remain not fully understood. Interestingly, seminal works during the last
decade have pointed out that the adult epicardium is reactivated after heart damage, re-expressing
some embryonic genes and contributing to cardiac remodeling. Therefore, the epicardium has been
proposed as a potential target in the treatment of cardiovascular disease. In this review, we summarize
the previous knowledge regarding the regulation of epicardial cell contribution during development
and the control of epicardial reactivation in cardiac repair after damage.Spanish Government BFU2015-67131
PID2019-107492GB-10
MiRNAs and Muscle Regeneration: Therapeutic Targets in Duchenne Muscular Dystrophy
This research was funded by Duchenne Parent Project Espana grants 2016, 2018 and 2019.microRNAs (miRNAs) are small non-coding RNAs required for the post-transcriptional control of gene expression. MicroRNAs play a critical role in modulating muscle regeneration and stem cell behavior. Muscle regeneration is affected in muscular dystrophies, and a critical point for the development of effective strategies for treating muscle disorders is optimizing approaches to target muscle stem cells in order to increase the ability to regenerate lost tissue. Within this framework, miRNAs are emerging as implicated in muscle stem cell response in neuromuscular disorders and new methodologies to regulate the expression of key microRNAs are coming up. In this review, we summarize recent advances highlighting the potential of miRNAs to be used in conjunction with gene replacement therapies, in order to improve muscle regeneration in the context of Duchenne Muscular Dystrophy (DMD).Duchenne Parent Project Espana grant 2016Duchenne Parent Project Espana grant 2018Duchenne Parent Project Espana grant 201
Understanding Epicardial Cell Heterogeneity during Cardiogenesis and Heart Regeneration
The outermost layer of the heart, the epicardium, is an essential cell population that contributes, through epithelial-to-mesenchymal transition (EMT), to the formation of different cell types and provides paracrine signals to the developing heart. Despite its quiescent state during adulthood, the adult epicardium reactivates and recapitulates many aspects of embryonic cardiogenesis in response to cardiac injury, thereby supporting cardiac tissue remodeling. Thus, the epicardium has been considered a crucial source of cell progenitors that offers an important contribution to cardiac development and injured hearts. Although several studies have provided evidence regarding cell fate determination in the epicardium, to date, it is unclear whether epicardium-derived cells (EPDCs) come from specific, and predetermined, epicardial cell subpopulations or if they are derived from a common progenitor. In recent years, different approaches have been used to study cell heterogeneity within the epicardial layer using different experimental models. However, the data generated are still insufficient with respect to revealing the complexity of this epithelial layer. In this review, we summarize the previous works documenting the cellular composition, molecular signatures, and diversity within the developing and adult epicardium
PITX2 Enhances the Regenerative Potential of Dystrophic Skeletal Muscle Stem Cells
Summary: Duchenne muscular dystrophy (DMD), one of the most lethal genetic disorders, involves progressive muscle degeneration resulting from the absence of DYSTROPHIN. Lack of DYSTROPHIN expression in DMD has critical consequences in muscle satellite stem cells including a reduced capacity to generate myogenic precursors. Here, we demonstrate that the c-isoform of PITX2 transcription factor modifies the myogenic potential of dystrophic-deficient satellite cells. We further show that PITX2c enhances the regenerative capability of mouse DYSTROPHIN-deficient satellite cells by increasing cell proliferation and the number of myogenic committed cells, but importantly also increasing dystrophin-positive (revertant) myofibers by regulating miR-31. These PITX2-mediated effects finally lead to improved muscle function in dystrophic (DMD/mdx) mice. Our studies reveal a critical role for PITX2 in skeletal muscle repair and may help to develop therapeutic strategies for muscular disorders. : Vallejo et al. show that PITX2c enhances the regenerative capability of mouse DYSTROPHIN-deficient satellite cells by increasing cell proliferation and the number of myogenic committed cells but importantly also increasing dystrophin-positive (revertant) myofibers by regulating miR-31. Keywords: PITX2, muscle stem cells, muscular dystrophy, miR-3
Contractile regulatory proteins tropomyosin and troponin-T as indicators of the modulatory role of retinoic acid
Retinoic acid (RA), the active metabolite of vitamin A, plays a significant role in regulating cardiac form and function throughout the life of the organism. Both cardiac morphogenesis and myocardial differentiation are affected by alterations in RA homeostasis. In order to test the effect of all-trans RA and 13-cis RA on cardiomyocyte differentiation, we studied the level and the subcellular compartmentalization of α-tropomyosin and troponin-T proteins in cultures of chick embryo cardiomyocytes obtained from Hamburger and Hamilton’s (HH) stage 22, 32 and 40 embryos. The retinoids increased the levels of α-tropomyosin and troponin-T in the cytoplasmic and cytoskeletal fractions of cells at all three stages of development. The greatest increases in α-tropomyosin occurred in the cytoplasmic fraction in HH22 cells cultured for 24 h with all-trans RA or 13-cis RA, whereas the greatest increases in troponin-T were found in the cytoplasmic fraction of HH32 cells exposed to retinoids for 24 h. In cultures treated for 48 h with retinoids, the levels of α-tropomyosin and troponin-T showed significant increases in the cytoplasmic compartment of cells treated in HH32-with respect to the control values. These findings are further evidence that RA plays a modulating role in the formation and reorganization of sarcomeric proteins during the process of cardiomyocyte maturation